Some researchers found that BEX2 was silenced in all tumor specimens and exhibited extensive promoter hypermethylation, and viral-mediated re-expression of BEX2 led to increased sensitivity to chemotherapy-induced apoptosis and potent tumor suppressor effects in vitro and in a xenograft mouse model (Foltz et al., 2006). Here, BEX2 is linked to neoplasm.